1-5 of 5
Miriam Kimpton
Close
Sort by
Journal Articles

Assessing the Feasibility of Thromboprophylaxis with Apixaban in JAK2-Positive Myeloproliferative Neoplasm Patients: The Airport-MPN Trial

Miriam Kimpton, Sonia Cerquozzi, Dominique Toupin, Pierre Villeneuve, Deborah Siegal, Marc Carrier, Aurelien Delluc
Journal: Blood
Blood (2023) 142 (Supplement 1): 1823.
https://doi.org/10.1182/blood-2023-175012
Published: 2023
Journal Articles

Management of Anticoagulation and Related Outcomes in Patients with Cancer-Associated Thrombosis and Thrombocytopenia: A Systematic Review and Meta-Analysis

Tzu-Fei Wang, Aurelien Delluc, Marc Carrier, Miriam Kimpton
Journal: Blood
Blood (2022) 140 (Supplement 1): 8538–8539.
https://doi.org/10.1182/blood-2022-164725
Published: 2022
Journal Articles

Cost-Utility Analysis of Apixaban Compared to Usual Care for the Primary Thromboprophylaxis of Ambulatory Cancer Patients Initiating Chemotherapy

Miriam Kimpton, MD, Srishti Kumar, MSc, Philip S. Wells, MDMSc,FRCP, Marc Carrier, MD, Kednapa Thavorn, MPharm, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 329.
https://doi.org/10.1182/blood-2019-127286
Published: 2019
Journal Articles

Incidence and Risk Factors of Venous Thromboembolism in Patients with Multiple Myeloma Receiving Immunomodulatory Agents

Miriam Kimpton, MD, Ryan Buyting, Daniel J Corsi, PhD, Natasha Rupani, MD, Marc Carrier, MD, MSc, Arleigh McCurdy, MD
Journal: Blood
Blood (2016) 128 (22): 2624.
https://doi.org/10.1182/blood.V128.22.2624.2624
Published: 2016
Journal Articles

Diagnosis of Isolated Sub-Segmental Pulmonary Embolism on Computed Tomography Pulmonary Angiography; How Sure Are We of the Diagnosis?

Miriam Kimpton, BA, Elena Pena Fernandez, MD, Carole Dennie, MD MSc, Rebecca Peterson, MD, Marc Carrier, MD, MSc
Journal: Blood
Blood (2011) 118 (21): 714.
https://doi.org/10.1182/blood.V118.21.714.714
Published: 2011